Journal of Controlled Release

Journal of Controlled Release is a biweekly journal published by Elsevier, founded in 1984 and devoted to the science and technology of controlled release and drug delivery, the official journal of the Controlled Release Society and the Japan Society of Drug Delivery System, indexed in MEDLINE, the Science Citation Index Expanded, Scopus and EMBASE, with a 2025 impact factor of 12.4Journal of Controlled Release 是 Elsevier 出版的双周刊，1984 年创刊，专注控释与药物递送的科学与技术，是控释学会与日本药物递送系统学会的官方期刊，被 MEDLINE、科学引文索引扩展版、Scopus 与 EMBASE 收录，2025 年影响因子为 12.4。

Scope

• Drug delivery systems and every aspect of pharmaceutics, from the design of dosage forms to their characterisation涵盖药物递送系统与药剂学各方面，从剂型设计到其表征。
• The physicochemical and biological properties of drugs, release mechanisms and in vivo performance涉及药物的理化与生物学性质、释放机制与体内表现。
• Formulation research and development across pharmaceutical, diagnostic, agricultural, environmental, cosmetic and food applications覆盖制药、诊断、农业、环境、化妆品与食品等领域的制剂研发。
• Work that advances fundamental understanding or demonstrates new technologies superior to current clinical standards in safety and efficacy优先发表推进基础理解，或证明新技术在安全性与有效性上优于现行临床标准的工作。
• Serving as the principal forum of the controlled release community through its links with the Controlled Release Society通过与控释学会的联系，充当控释领域的主要学术论坛。

History

• The journal was founded in 1984 with Jorge Heller and Jan Feijen as its founding editors该刊 1984 年创刊，创始编辑为 Jorge Heller 与 Jan Feijen。
• It has been the official journal of the Controlled Release Society and is published by Elsevier该刊一直是控释学会的官方期刊，由 Elsevier 出版。
• It now appears in roughly twenty-four to twenty-six issues a year, making it a de facto biweekly该刊目前每年出版约 24 至 26 期，事实上已是双周刊。
• Its impact factor has climbed steadily over the past decade and reached 12.4 in 2025近十年来其影响因子稳步上升，2025 年达到 12.4。

Editors

• The editor-in-chief is Stefaan De Smedt of Ghent University in Belgium, who works on advanced drug delivery, nanomedicine and nucleic acids and took up the post in January 2023现任主编为比利时根特大学的 Stefaan De Smedt，研究先进药物递送、纳米药物与核酸，2023 年 1 月上任。
• The deputy editors-in-chief are Paolo Caliceti of the University of Padua, Yunching Chen of National Tsing Hua University and Yoon Yeo of Purdue University副主编为帕多瓦大学的 Paolo Caliceti、台湾国立清华大学的 Yunching Chen 与普渡大学的 Yoon Yeo。
• The editorial roster lists about one hundred and eighty editors and board members, and the founding editors Jan Feijen and Jorge Heller are recorded as emeritus编辑团队名单约有一百八十名编辑与编委，创始编辑 Jan Feijen 与 Jorge Heller 被列为荣休。
• Manuscripts are screened by the editors and then assessed by independent referees under a single anonymized model, and the journal is hybrid open access with a charge of about 4560 US dollars稿件先经编辑初筛，再以单匿名方式送独立评审；该刊为混合开放获取，版面费约 4560 美元。